Purchase Order 36C25726P0299
- Not listed
- This federal contract award is for the delivery of a replacement heart valve to the Department of Veterans Affairs (VA). The contract, valued at $12,655.00, was awarded to the prime contractor Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a firm-fixed price purchase order with a completion date of December 31, 2024. No set-aside designation was specified. Abbott Laboratories Inc. is a large pharmaceutical and medical device manufacturer that provides a...
- The Department of Veterans Affairs Veterans Health Administration awarded Abbott Laboratories Abbott Vascular Inc. Division a $15,815 purchase order contract to provide heart valves. As the prime contractor, Abbott Vascular will deliver its cardiac devices to Veterans Integrated Service Network 4 (VHA VISN 4), the regional health network serving veterans in Southern California. Performance will take place in Temecula, California and last from October 6, 2023 through January 8, 2024 under firm...
- This federal contract award to Abbott Laboratories Inc., valued at $24,436.00, is for the delivery of an Express Report: Implant Heart Valve Replacement to the Department of Veterans Affairs (VA), Veterans Integrated Service Network 17. The contract is a firm fixed-price purchase order with a completion date of October 31, 2024. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is a large medical device manufacturer that has been awarded numerous federal contracts to provide...
- This is a $26,181 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc. through its Abbott Vascular division. The contract is for the delivery of a replacement heart valve to support VA healthcare services. Abbott Vascular is a manufacturer of medical devices for cardiovascular disease and stroke, including products like stents, pacemakers, and implantable cardiac monitors. They have been awarded multiple...
- This is a $12,218 firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., through its Abbott Vascular Inc. division. The contract is for the replacement of a heart valve, with a completion date of December 31, 2024. Abbott Vascular specializes in medical devices for cardiovascular disease and stroke, and has been awarded numerous federal contracts to provide a range of cardiovascular devices and systems to the VA and Defense Health...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a firm fixed-price purchase order valued at $31,693.60 by the Department of Veterans Affairs' Veterans Integrated Service Network 12 for an LVAD (Left Ventricular Assist Device) system for veteran patient care. The contract, awarded on October 30, 2025, with an ultimate completion date of December 31, 2025, will be performed in Santa Clara, California. This award was made without a set-aside designation,...
- This is a $12,655 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., through its Abbott Vascular Inc. division, to provide an express report on heart valve replacement. The contract does not have a set-aside designation. Abbott Vascular is a medical device manufacturer that has been awarded multiple contracts and blanket purchase agreements (BPAs) by the VA and Defense Health Agency to supply cardiovascular products and services....
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order contract valued at $24,730 by Veterans Integrated Service Network 9 (VISN 9), the civilian healthcare component of the Department of Veterans Affairs. The contract, issued on December 29, 2025, with an ultimate completion date of January 30, 2026, carries a firm fixed price structure and was awarded without set-aside designation, indicating full and open competition. The place of performance is...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a firm fixed-price purchase order valued at $24,625 by Veterans Integrated Service Network 12 (VISN 12) for an implant to support veterans' medical needs. The contract, awarded on January 13, 2026, with an ultimate completion date of April 13, 2026, was issued without a set-aside designation, indicating full and open competition. Performance will take place in Santa Clara, California, where Abbott Vascular...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 20 (VISN 20) on February 3, 2026, for surgical implants valued at $49,824.01, with an ultimate completion date of February 2, 2027. The contract was awarded without set-aside designation through full and open competition and will be performed in Santa Clara, California. This purchase order represents a discrete medical device procurement...
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 17 on February 25, 2026, for replacement heart valves with a ceiling value of $26,646. The contract, which carries no set-aside designation, will be performed in San Antonio, Texas, and is scheduled for completion by May 31, 2026. This award reflects Abbott's established role as a critical supplier of advanced cardiovascular medical technologies to the Department of Veterans Affairs, with the company maintaining multiple indefinite delivery contracts across various VISN networks for transcatheter prosthetic surgical heart valves and related cardiac implants. Abbott Laboratories has demonstrated substantial competitive positioning within federal healthcare procurement through its comprehensive portfolio of cardiovascular devices and medical technologies. The company's federal contracting history includes multiple indefinite delivery contracts with VISN networks and the Defense Logistics Agency, including a consignment heart valve IDC with VISN 17 extending through September 2029, positioning Abbott as an essential supplier to the VA's complex cardiac surgical programs. This purchase order represents a discrete procurement leveraging Abbott's established contracting relationships and capability to deliver specialized surgical implants that directly support veteran healthcare outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.6k | 2/25/26 |